1.
Glaucoma progression in patients receiving intravitreal anti-VEGF treatment for neovascular age-related macular degeneration.
Pirinen Inka, Leinonen Sanna, Helminen Mika, Hujanen Pekko, Vaajanen Anu, Tuulonen Anja et al.
Acta OphthalmolNov 20224 citationsCohort Study
This study found that anti-VEGF treatment for nAMD may accelerate glaucoma progression, suggesting careful monitoring is needed for co-existing conditions.